SB2101

Pharmaceutical companies; creating the Oklahoma Medicine Injury Justice Act. Emergency.

Introduced·2/2/26
Int Text

Oklahoma SB2101 establishes the Oklahoma Medicine Injury Justice Act, ensuring pharmaceutical companies are liable for harm caused by their products.

Oklahoma SB2101, the Oklahoma Medicine Injury Justice Act, ensures that pharmaceutical companies are directly liable for harm caused by their products. This includes compensatory damages for medical expenses, lost wages, and other economic losses, as well as noneconomic damages for pain and suffering. The act mandates that all claims be heard in Oklahoma state courts, prohibiting arbitration or other limitations on access to justice. It also asserts that federal immunities and sovereignty do not apply to claims brought in Oklahoma state courts.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Rules Committee
Next
Committee decision

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

History

Feb 3

Senate

Second Reading referred to Rules

Feb 2

Senate

First Reading

Feb 2

Senate

Authored by Senator Deevers